endometrial cancer
FDA Approves GSK's Jemperli With Ventana CDx for dMMR Endometrial Cancer
The FDA also approved the Ventana MMR RxDx panel as a companion diagnostic to select endometrial cancer patients for treatment with dostarlimab.
Promega to Develop MSI Assay as CDx for Incyte Endometrial Cancer Drug
Promega will develop its microsatellite instability assay as a companion diagnostic for Incyte's anti-PD-1 drug candidate retifanlimab in endometrial cancer.
Cancer, Pathology Organizations Developing Clinical Guidelines for MMR, MSI Testing
The groups have written draft recommendations and are now asking for public comment from pathologists and other stakeholders.
Guardant Health Liquid Biopsy Test Gets Expanded Medicare Coverage for Solid Tumors
Palmetto has expanded the local coverage determination for the Guardant360 liquid biopsy assay to be used with the majority of advanced solid tumors.
A*STAR Spinoff, IMCB Establish Immuno-Oncology Lab
The IMCB-A!maginostic Joint Lab of Excellence will provide AI- and machine learning-based solutions to support computational digital and multiplex pathology.
Jul 11, 2019